Cargando…
Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic
Since December 2019, the human populations of the 195 global countries continue experiencing grave health and life threats due to the current COVID-19 pandemic. As a result of the novelty of the pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), at present there is lack of p...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS).
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718590/ https://www.ncbi.nlm.nih.gov/pubmed/33285298 http://dx.doi.org/10.1016/j.tracli.2020.11.004 |
_version_ | 1783619518931664896 |
---|---|
author | Dassarma, Barsha Tripathy, Satyajit Matsabisa, Motlalepula |
author_facet | Dassarma, Barsha Tripathy, Satyajit Matsabisa, Motlalepula |
author_sort | Dassarma, Barsha |
collection | PubMed |
description | Since December 2019, the human populations of the 195 global countries continue experiencing grave health and life threats due to the current COVID-19 pandemic. As a result of the novelty of the pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), at present there is lack of preventive as well as therapeutic options for treating and managing the infection. The use of ancient immunotherapeutic technique – the convalescent plasma (CP) therapy, may act as an immediate and available option to control the COVID-19 pandemic. This review provides a concept and understanding on the CP therapy, its potential to control SARS-CoV-2 pandemic. The CP therapy might act as an immediate saviour for society from the virus. Although the CP therapy has exert affirmative result against COVID-19 it has not been recommended for long time use in COVID-19 and this review gives support for its possible application. |
format | Online Article Text |
id | pubmed-7718590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS). |
record_format | MEDLINE/PubMed |
spelling | pubmed-77185902020-12-07 Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic Dassarma, Barsha Tripathy, Satyajit Matsabisa, Motlalepula Transfus Clin Biol Review Article Since December 2019, the human populations of the 195 global countries continue experiencing grave health and life threats due to the current COVID-19 pandemic. As a result of the novelty of the pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), at present there is lack of preventive as well as therapeutic options for treating and managing the infection. The use of ancient immunotherapeutic technique – the convalescent plasma (CP) therapy, may act as an immediate and available option to control the COVID-19 pandemic. This review provides a concept and understanding on the CP therapy, its potential to control SARS-CoV-2 pandemic. The CP therapy might act as an immediate saviour for society from the virus. Although the CP therapy has exert affirmative result against COVID-19 it has not been recommended for long time use in COVID-19 and this review gives support for its possible application. Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS). 2021-02 2020-12-05 /pmc/articles/PMC7718590/ /pubmed/33285298 http://dx.doi.org/10.1016/j.tracli.2020.11.004 Text en © 2020 Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Article Dassarma, Barsha Tripathy, Satyajit Matsabisa, Motlalepula Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic |
title | Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic |
title_full | Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic |
title_fullStr | Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic |
title_full_unstemmed | Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic |
title_short | Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic |
title_sort | emergence of ancient convalescent plasma (cp) therapy: to manage covid-19 pandemic |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718590/ https://www.ncbi.nlm.nih.gov/pubmed/33285298 http://dx.doi.org/10.1016/j.tracli.2020.11.004 |
work_keys_str_mv | AT dassarmabarsha emergenceofancientconvalescentplasmacptherapytomanagecovid19pandemic AT tripathysatyajit emergenceofancientconvalescentplasmacptherapytomanagecovid19pandemic AT matsabisamotlalepula emergenceofancientconvalescentplasmacptherapytomanagecovid19pandemic |